Skip to content

CRYSTAPHARM

Active
Private limited companyfounded 200125 yrs activeNoorderlaan 76, 8790 Waregem, BelgiumKBO/BCE: BE 0475.358.495
Summary

CRYSTAPHARM has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.3m and a net result of €635,309. Equity remains stable across the filed fiscal years (±2.1% per year). Its solvency ranks better than 35% of 3330 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability71▲+21
Solvency52▼-3
Growth58=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €90,000 at 30 days acceptable
Liquidity short (current ratio 0.13 against 0.27 in 2024; short-term debt: 15.6% and cash: 1.6% of total assets), and 73% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 69
Relative position
BE, all sectors
reference
Legal and accounting activities (NACE 69)
about 77% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 25 years 0 30 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
27%
Return on assets
13.4%
Age of the figures
15 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 19-09-2025, 134 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
134 d early
2024
114 d early
2022
on the day
2021
78 d late
2020
14 d late
2019
61 d late
2018
1 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 14 days before the deadline; the sector median for financial year 2024 is 9 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-06-2026 close28-09-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 20 July 2001, CRYSTAPHARM was incorporated.1 Total assets went from EUR 2 million in 2018 to EUR 4.7 million in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, abbreviated schema

Equity
€1.3m▲ 0.3%
2024 · €1.3m
Total assets
€4.7m▲ 12.7%
2024 · €4.2m
Net result
€635,309▲ 198%
2024 · €213,273
Working capital
-€641,227▼ 294%
2024 · -€162,836
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 69, Legal and accounting activities, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20202021202220242025
Operating result-€32,966▲ 44.1%-€32,983▼ 0.1%-€42,525▼ 28.9%€246,764-€338,666▲ 37.2%
Net result-€42,167below the sector's middle half▼ 354%-€54,681below the sector's middle half▼ 29.7%-€81,297below the sector's middle half▼ 48.7%€213,273within the sector's middle half-€635,309above the sector's middle half▲ 198%
Equity€1.4mabove the sector's middle half▼ 2.9%€1.3mabove the sector's middle half▼ 3.9%€1.3mabove the sector's middle half▼ 6.0%€1.3mabove the sector's middle half-€1.3mabove the sector's middle half▲ 0.3%
Total assets€1.9mwithin the sector's middle half▼ 2.0%€1.9mabove the sector's middle half▼ 1.4%€1.4mabove the sector's middle half▼ 27.9%€4.2mabove the sector's middle half-€4.7mabove the sector's middle half▲ 12.7%
Debt€515,081▲ 0.6%€543,438▲ 5.5%€98,522▼ 81.9%€2.9m-€3.5m▲ 18.1%
Working capital€910,453above the sector's middle half▼ 1.5%€912,065above the sector's middle half▲ 0.2%€1.2mabove the sector's middle half▲ 35.7%-€162,836below the sector's middle half--€641,227below the sector's middle half▼ 294%
Solvency73.1%above the sector's middle half▼ 0.7pp71.2%within the sector's middle half▼ 1.9pp92.8%above the sector's middle half▲ 21.6pp30.3%within the sector's middle half-27.0%within the sector's middle half▼ 3.3pp
Current ratio69.77above the sector's middle half▲ 9.0822.00above the sector's middle half▼ 47.7713.57above the sector's middle half▼ 8.430.27below the sector's middle half-0.13below the sector's middle half▼ 0.14
Return on assets (ROA)-2.2%below the sector's middle half▼ 1.7pp-2.9%below the sector's middle half▼ 0.7pp-6.0%below the sector's middle half▼ 3.1pp5.1%within the sector's middle half-13.4%within the sector's middle half▲ 8.3pp
above within below the middle half (P25 to P75) of NACE 69, Legal and accounting activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Why a figure moved sharply
  • 2025 Net result +198% on 2024. The previous fiscal year ran 18 months, this one 12.
Result per fiscal year
Operating resultNet result
-€200,000€0€200,000€400,000€600,000Operating result 2020: -€32,966-€32,966Net result 2020: -€42,167-€42,167Operating result 2021: -€32,983-€32,983Net result 2021: -€54,681-€54,681Operating result 2022: -€42,525-€42,525Net result 2022: -€81,297-€81,297Operating result 2024: €246,764€246,764Net result 2024: €213,273€213,273Operating result 2025: €338,666€338,666Net result 2025: €635,309€635,30920202021202220242025-€200,000€0€200,000€400,000€600,000Operating result 2022: -€42,525-€42,500Net result 2022: -€81,297-€81,300Operating result 2024: €246,764€247,000Net result 2024: €213,273€213,000Operating result 2025: €338,666€339,000Net result 2025: €635,309€635,000202220242025
The operating result rises in 2025; 2025 is 37% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €4.7m
Fixed assets €4.6m ▲ 12.0%
Current assets €98,442 ▲ 62.1%
Equity and liabilities €4.7m
Equity €1.3m ▲ 0.3%
Debt €3.5m ▲ 18.1%
Debt's share of the balance-sheet total rises from 69.7% to 73.0%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
Debt to equity
2.70▲
2024 · 2.30
ROE
49.6%▲
2024 · 16.7%
Debt ≤ 1 year
€739,670▲
2024 · €223,556
Debt > 1 year
€2.7m▲
2024 · €2.7m
Income taxes
€973
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 51 lines
Balance sheet Code20242025
Assets
Total assets20/58€4.2m€4.7m▲
Fixed assets21/28€4.1m€4.6m▲
Financial fixed assets28€4.1m€4.6m▲
Current assets29/58€60,720€98,442▲
Amounts receivable after more than one year29€0-
Other amounts receivable291€0-
Amounts receivable within one year40/41€38,911€23,195▼
Trade receivables40€37,510€23,168▼
Other amounts receivable41€1,401€27▼
Current investments50/53€14€14=
Cash at bank and in hand54/58€21,794€75,233▲
Deferred charges and accrued income490/1€0-
Equity and liabilities
Total equity and liabilities10/49€4.2m€4.7m▲
Equity10/15€1.3m€1.3m▲
Contributions10/11€18,600€18,600=
Reserves13€1.3m€1.3m▲
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Distributable reserves133€1.3m€1.3m▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€2.9m€3.5m▲
Amounts payable after more than one year17€2.7m€2.7m▲
Financial debts170/4-€281,956
Other amounts payable178/9€2.7m€2.4m▼
Amounts payable within one year42/48€223,556€739,670▲
Current portion of amounts payable after more than one year42-€49,495
Trade debts44€3,419€0▼
Suppliers440/4€3,419€0▼
Taxes, remuneration and social security45€20,137€59,174▲
Taxes450/3€20,137€59,174▲
Other amounts payable47/48€200,000€631,000▲
Accrued charges and deferred income492/3-€956
Income statement Code20242025
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€0-
Other operating charges640/8€2,682€1,342▼
Gross operating margin9900€249,446€340,008▲
Operating profit (loss)9901€246,764€338,666▲
Financial income75/76B€41,349€408,700▲
Recurring financial income75€41,349€408,700▲
Financial charges65/66B€74,840€111,085▲
Recurring financial charges65€74,840€111,085▲
Profit (loss) for the period before taxes9903€213,273€636,281▲
Income taxes67/77-€973
Profit (loss) for the period9904€213,273€635,309▲
Profit (loss) for the period to be appropriated9905€213,273€635,309▲
Appropriation of the result
Profit (loss) to be appropriated9906€213,273€635,309▲
Transfer from equity791/2€0-
Transfer to equity691/2€13,273€4,309▼
To other reserves6921€13,273€4,309▼
Profit to be distributed694/7€200,000€631,000▲
Return on contributions (dividend)694€200,000€566,000▲
Directors or managers695-€65,000

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20202021202220242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€23,134€23,134----
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4--€3,401€0--
Other operating charges640/8-€1,069€4,681€2,682€1,342▼ 50.0%
Gross operating margin9900-€8,627-€8,780-€34,443€249,446€340,008▲ 36.3%
Operating profit (loss)9901-€32,966-€32,983-€42,525€246,764€338,666▲ 37.2%
Financial income75/76B-€24,155€50,142€41,349€408,700▲ 888%
Recurring financial income75€20,192€24,155€50,142€41,349€408,700▲ 888%
Financial charges65/66B-€45,854€88,914€74,840€111,085▲ 48.4%
Recurring financial charges65€29,394€45,854€40,216€74,840€111,085▲ 48.4%
Non-recurring financial charges66B--€48,698---
Profit (loss) for the period before taxes9903-€42,167-€54,681-€81,297€213,273€636,281▲ 198%
Income taxes67/77----€973-
Profit (loss) for the period9904-€42,167-€54,681-€81,297€213,273€635,309▲ 198%
Profit (loss) for the period to be appropriated9905-€42,167-€54,681-€81,297€213,273€635,309▲ 198%
Line20202021202220242025Change
Assets
Total assets20/58€1.9m€1.9m€1.4m€4.2m€4.7m▲ 12.7%
Fixed assets21/28€990,458€932,324€25,000€4.1m€4.6m▲ 12.0%
Tangible fixed assets22/27€930,458€907,324----
Land and buildings22-€454,037----
Plant, machinery and equipment23-€987----
Furniture and vehicles24-€2,661----
Other tangible fixed assets26-€449,639----
Financial fixed assets28€60,000€25,000€25,000€4.1m€4.6m▲ 12.0%
Current assets29/58€923,693€955,503€1.3m€60,720€98,442▲ 62.1%
Amounts receivable after more than one year29-€260,000€370,000€0--
Other amounts receivable291-€260,000€370,000€0--
Amounts receivable within one year40/41€86,584€82,135€12,780€38,911€23,195▼ 40.4%
Trade receivables40-€4,043€7,850€37,510€23,168▼ 38.2%
Other amounts receivable41-€78,093€4,930€1,401€27▼ 98.0%
Current investments50/53€483,074€464,195€432,414€14€14=
Cash at bank and in hand54/58€144,746€116,619€464,491€21,794€75,233▲ 245%
Deferred charges and accrued income490/1-€32,553€56,930€0--
Equity and liabilities
Total equity and liabilities10/49€1.9m€1.9m€1.4m€4.2m€4.7m▲ 12.7%
Equity10/15€1.4m€1.3m€1.3m€1.3m€1.3m▲ 0.3%
Contributions10/11-€18,600€18,600€18,600€18,600=
Reserves13€1.4m€1.3m€1.2m€1.3m€1.3m▲ 0.3%
Non-distributable reserves130/1-€1,860€1,860€0--
Reserves not available under the articles1311-€1,860€1,860€0--
Distributable reserves133-€1.3m€1.2m€1.3m€1.3m▲ 0.3%
Profit (loss) carried forward14---€0€0-
Amounts payable17/49€515,081€543,438€98,522€2.9m€3.5m▲ 18.1%
Amounts payable after more than one year17€500,000€500,000-€2.7m€2.7m▲ 0.5%
Financial debts170/4-€500,000--€281,956-
Other amounts payable178/9---€2.7m€2.4m▼ 9.9%
Amounts payable within one year42/48€13,240€43,438€98,522€223,556€739,670▲ 231%
Current portion of amounts payable after more than one year42----€49,495-
Trade debts44€3,510€5,983€12,115€3,419€0▼ 100%
Suppliers440/4-€5,983€12,115€3,419€0▼ 100%
Taxes, remuneration and social security45--€14,437€20,137€59,174▲ 194%
Taxes450/3--€14,437€20,137€59,174▲ 194%
Other amounts payable47/48-€37,455€71,971€200,000€631,000▲ 216%
Accrued charges and deferred income492/3----€956-
Line20202021202220242025Change
Profit (loss) for the period9904-€42,167-€54,681-€81,297€213,273€635,309▲ 198%
+ Depreciation and write-downs630€23,134€23,134----
Operating cash flow (approximation)-€19,034-€31,547-€81,297€213,273€635,309▲ 198%
Investment in fixed assets (approximation)-€35,000€907,324--€497,872-
Change in cash--€28,127€347,872-€53,439-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-01-2027
2025
19-09
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
30-06
Financial Highest result since 2018net €635,309 ▲198%
Operating result €338,666, net result €635,309, both a record.
2024
09-10
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
30-06
Financial Back to profitnet €213,273
Net result €213,273 after 5 loss-making years.
2023
31-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
17-10
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 78 days late
2021
14-08
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 14 days late
2020
30-09
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 61 days late
2019
30-07
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
07-07
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2017
31-07
NBB filing Annual accounts filed
fiscal year 2016 · micro schema
2016
30-06
NBB filing Annual accounts filed
fiscal year 2015 · abbreviated schema
2010
15-06
State Gazette act General meeting · Statutes amendment
Share issue · Auditor report · Frank Liesse
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts

We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Waregem · 1 establishment unit since 2001
seat establishment The establishment unit on the map
Ground area
322 m²
Building footprint
273 m²
Volume, LiDAR
1,962 m³
Parcel 34040C0310/02E003, Flanders · tallest building 13.9 m, ±3 floors. Linked by address, not a title deed.
16 companies at this address See who is registered here
1 establishment unit
CRYSTAPHARM
Noorderlaan 76, 8790 WaregemCertified accountants and tax accountants
since 20012.100.433.149
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
34040C0310/02E003 Flanders 322 m² 1 · 273 m² 13.9 m · 3 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

5 owners · 1 holding

Owners 5

Holdings 1

According to the annual accounts to 30-06-2025 of CRYSTAPHARM and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Recognitions · licences · registrations

Legal Entity Identifier

5493009IVA7XLW3YCT03
no longer live in the LEI register

Similar companies · same sector, comparable size

Of 12,174 companies in sector 69201 we hold annual accounts for 7,641. 3,970 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded20-07-2001
Fiscal year end30-06
Activities, NACEBEL 2025
69201Certified accountants and tax accountants
Contact
E-mail jmstassen@yahoo.comWaregem
E-invoicing
Reachable via Peppol
Peppol ID 0208:0475358495
Registered 05-11-2025

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.